A Systematic Review of the Symptom Distress Scale in Advanced Cancer Studies.
A Systematic Review of the Symptom Distress Scale in Advanced Cancer Studies.
复制标题
DOI：
10.1097/ncc.0000000000000292
复制
发表时间：
2016-07
期刊：
影响因子：
2.6
通讯作者：
Wilkie DJ
中科院分区：
文献类型：
--
作者：
Stapleton SJ;Holden J;Epstein J;Wilkie DJ
13项症状困扰量表（SDS）是一种广泛使用的症状测量工具，但尚不存在总结其在晚期癌症患者中使用所产生的症状知识的系统性综述。我们对研究文献进行了系统回顾，其中研究者使用SDS作为晚期癌症患者症状的衡量标准。我们在PubMed、CINAHL、EMBASE和Web-of-Science中检索了1978年至2013年期间发表的主要研究，这些研究使用SDS作为晚期癌症患者的测量工具。共检索到文献918篇，应用纳入/排除标准，纳入21篇文献和2篇学位论文。大多数研究者采用描述性、横断面研究设计，使用方便样本进行。SDS总分、单项评分、年龄范围和平均值、性别分布、癌症类型、癌症分期和心理测量学特性的不一致报告使得比较困难。可用的平均SDS评分范围为17.6-38.8。报告的内部一致性从.67到.88不等。加权平均值表明疲劳是最普遍和最令人痛苦的症状。食欲高于疼痛强度和疼痛频率。SDS以告知研究人员或临床医生关于受访者报告的症状困扰的严重程度的方式捕获患者的症状体验。SDS广泛用于各种癌症诊断。SDS是临床医生可以用来评估晚期癌症患者经历的11种症状的工具。
The 13-item Symptom Distress Scale (SDS) is a widely used symptom measurement tool yet a systematic review summarizing the symptom knowledge generated from its use in patients with advanced cancer is nonexistent. We performed a systematic review of the research literature in which investigators utilized the SDS as the measure of symptoms in patients with advanced cancer. We searched PubMed, CINAHL, EMBASE, and Web-of-Science for primary research studies published between 1978 through 2013 that utilized the SDS as the measurement tool in patients with advanced cancer. 918 documents were found. Applying inclusion/exclusion criteria, 21 articles and 2 dissertations were included. The majority of investigators utilized descriptive, cross-sectional research designs conducted with convenience samples. Inconsistent reporting of SDS total scores, individual item scores, age ranges and means, gender distributions, cancer types, cancer stages, and psychometric properties made comparisons difficult. Available mean SDS scores ranged from 17.6–38.8. Reports of internal consistency ranged from .67 to .88. Weighted means indicated fatigue to be the most prevalent and distressing symptom. Appetite ranked higher than pain intensity and pain frequency. The SDS captures the patient’s symptom experience in a manner that informs the researcher or clinician about the severity of the respondents’ reported symptom distress. The SDS is widely used in a variety of cancer diagnoses. The SDS is a tool clinicians can use to assess 11 symptoms experienced by patients with advanced cancer.